ClinicalTrials.Veeva

Menu

Efficacy of the DOMINO Diet App in IBS (EDDI)

U

Universitaire Ziekenhuizen KU Leuven

Status

Enrolling

Conditions

Irritable Bowel Syndrome

Treatments

Other: Dietary intervention: low FODMAP diet
Other: Dietary intervention: DOMINO app

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to evaluate whether the DOMINO diet application is an effective tool in the treatment of Irritable bowel syndrome in tertiary care. Furthermore, this study aims to determine the response rate of the strict low FODMAP diet in non-responders to the DOMINO diet.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
  2. Use of highly effective methods of birth control; defined as those that, alone or in combination, result in low failure rate (i.e., less than 1% per year) when used consistently and correctly; such as implants, injectables, combined oral contraceptives, some IUDs, true sexual abstinence (i.e. refraining from heterosexual intercourse during the entire period of risk associated with the Trial treatment(s)) or commitment to a vasectomised partner.
  3. Patients with irritable bowel syndrome according to Rome IV diagnostic criteria
  4. Patients ages between 18 and 70 years old

Exclusion criteria

  1. Participant has a history of any major psychiatric disorders (including those with a major psychosomatic element to their gastrointestinal disease), depression, alcohol or substance abuse in the last 2 years
  2. Any disorder, which in the Investigator's opinion might jeopardise the participant's safety or compliance with the protocol
  3. Any prior or concomitant treatment(s) that might jeopardise the participant's safety or that would compromise the integrity of the Trial
  4. Female who is pregnant, breast-feeding or intends to become pregnant or is of child-bearing potential and not using an adequate, highly effective contraceptive
  5. Participation in an interventional Trial with an investigational medicinal product (IMP) or device
  6. Patients presenting with predominant symptoms of functional dyspepsia (FD) and of gastro-oesophageal reflux disease (GERD)
  7. Patients following a diet interfering with the study diet in opinion of the investigator
  8. Patients who already followed the low FODMAP diet under guidance of a trained dietitian without success

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

DOMINO app - DOMINO app
Other group
Description:
The patients start with the DOMINO diet (8 weeks). Patients that experienced symptom improvement, will continue with the DOMINO diet (6 weeks).
Treatment:
Other: Dietary intervention: DOMINO app
DOMINO app - low FODMAP diet
Active Comparator group
Description:
The patients start with the DOMINO diet (8 weeks). Patients that experienced no symptom improvement, will switch to the strict low FODMAP diet (6 weeks).
Treatment:
Other: Dietary intervention: DOMINO app
Other: Dietary intervention: low FODMAP diet

Trial contacts and locations

1

Loading...

Central trial contact

Karen Routhiaux; Jan Tack

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems